5912-19-6 Usage
Uses
Used in Pharmaceutical Industry:
2,3-dihydro-1H-pyrrolo[3,2-c]pyridine hydrochloride is used as a reactant for the synthesis of heterocyclic compounds, which are essential in the development of new drugs and therapeutic agents. These heterocyclic compounds can exhibit a wide range of biological activities, making them valuable for the treatment of various diseases and medical conditions.
Used in Enzyme Inhibition:
2,3-dihydro-1H-pyrrolo[3,2-c]pyridine hydrochloride is also used as an enzyme inhibitor in the synthetic preparation of heterocyclic compounds. By inhibiting specific enzymes, 2,3-dihydro-1H-pyrrolo[3,2-c]pyridine hydrochloride can potentially modulate biological processes and pathways, leading to the development of novel therapeutic strategies for various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 5912-19-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,9,1 and 2 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 5912-19:
(6*5)+(5*9)+(4*1)+(3*2)+(2*1)+(1*9)=96
96 % 10 = 6
So 5912-19-6 is a valid CAS Registry Number.
5912-19-6Relevant academic research and scientific papers
NOVEL PDE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION
-
Page/Page column 27, (2009/12/28)
The present invention relates to novel heterocyclic compounds of general formula (I), which are phosphodiesterase inhibitors (PDEs), in particular phosphodiesterase type 4 inhibitors, pharmaceutical compositions containing them, and processes for their preparation. These novel PDEs are useful in treating allergic and inflammatory diseases (such as asthma, COPD, allergic rhinitis, allergic conjunctivitis, respiratory distress syndrome, chronic bronchitis, nephritis, rheumatoid spondylitis, osteoarthritis, atopic dermatitis, eosinophilic granuloma, psoriasis, rheumatoid septic shock, ulcerative colitis, multiple sclerosis, chronic inflammation, Crohn's syndrome and central nervous system(CNS) disorders) and for inhibiting the production of Tumor Necrosis Factor(TNF-α).
